文献速递重症综合管理与镇静镇痛心脑血管急症

目标温度管理期间使用神经肌肉阻滞与神经功能结局的关联

The association between neuromuscular blockade use during target temperature management and neurological outcomes.
PubMed 文献 · Am J Emerg Med · 2020-08-03
一句话结论在院外心脏骤停患者的目标温度管理中,使用神经肌肉阻滞与出院时良好神经功能结局及生存率均无独立关联。

本研究为日本J-PULSE-HYPO注册研究的二次分析,纳入431例院外心脏骤停(OHCA)患者,其中353例(81.9%)在目标温度管理(TTM)期间使用了神经肌肉阻滞(NMB)。多变量logistic回归显示,NMB使用与出院时良好神经功能结局(OR 0.96,95%CI 0.42-2.18,p=0.918)及生存率(OR 0.83,95%CI 0.31-2.02,p=0.688)均无独立关联。调整协变量后,NMB组与非NMB组的预测良好神经功能结局概率分别为53.6%(95%CI 50.2-57.0)%与58.0%(95%CI 50.4-65.6)%(p=0.304),生存率分别为77.1%(95%CI 74.7-79.5)%与75.8%(95%CI 70.5-81.0)%(p=0.647),均无显著差异。结论提示,TTM期间使用NMB与OHCA患者神经功能结局及生存率无关。

要点

  • 在OHCA后接受TTM的患者中,NMB使用与出院时良好神经功能结局无独立关联(OR 0.96,95%CI 0.42-2.18,p=0.918)。
  • NMB使用与出院时生存率亦无独立关联(OR 0.83,95%CI 0.31-2.02,p=0.688)。
  • 调整协变量后,NMB组与非NMB组的预测良好神经功能结局概率分别为53.6%与58.0%,差异无统计学意义(p=0.304)。
  • 调整协变量后,NMB组与非NMB组的预测生存率分别为77.1%与75.8%,差异无统计学意义(p=0.647)。
  • 本研究为J-PULSE-HYPO注册研究的二次分析,NMB使用率为81.9%(353/431)。

适用人群与场景

  • 日本J-PULSE-HYPO注册研究中纳入的院外心脏骤停(OHCA)患者,共431例进行分析。

研究设计与关键结果

  • 研究类型:J-PULSE-HYPO注册研究的二次分析,纳入431例OHCA患者,其中353例(81.9%)在TTM期间使用NMB。
  • 主要终点:出院时良好神经功能结局(脑功能分级1-2级);多变量logistic回归显示NMB使用与良好神经功能结局无独立关联(OR 0.96,95%CI 0.42-2.18,p=0.918)。
  • 关键次要终点:出院时生存率;NMB使用与生存率无独立关联(OR 0.83,95%CI 0.31-2.02,p=0.688)。
  • 调整协变量后,NMB组与非NMB组的预测良好神经功能结局概率分别为53.6%(95%CI 50.2-57.0)%与58.0%(95%CI 50.4-65.6)%,p=0.304。
  • 调整协变量后,NMB组与非NMB组的预测生存率分别为77.1%(95%CI 74.7-79.5)%与75.8%(95%CI 70.5-81.0)%,p=0.647。

证据类型、等级与局限

  • 证据类型:基于注册数据的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在OHCA患者TTM期间使用NMB与良好神经功能结局及生存率无关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: To date, no study has comprehensively analyzed the association between neuromuscular blockade (NMB) during target temperature management (TTM) and the neurological outcomes after out-of-hospital cardiac arrest (OHCA) using a multicenter dataset. We aimed to examine the association between NMB during TTM after cardiac arrest and neurological outcomes after OHCA.

METHODS: This study was a secondary analysis of the Japanese Population-based Utstein-style study with defibrillation and basic/advanced Life Support Education and implementation-Hypothermia (J-PULSE-HYPO) study registry. The exposure of the current study was the use of NMB during TTM. The primary outcome was favorable neurological outcome, i.e., a cerebral performance category of 1-2, at hospital discharge.

RESULTS: Of the 452 patients with OHCA enrolled in the J-PULSE-HYPO study, 431 were analyzed. NMB was used in 353 patients (81.9%). Multivariable logistic regression analysis revealed that NMB use was not independently associated with favorable outcomes [odds ratio (OR), 0.96; 95% confidence interval (CI), 0.42-2.18; p = .918)] or survival at discharge (OR, 0.83; 95% CI, 0.31-2.02; p = .688). After adjusting the covariates, the predicted probabilities did not reveal significant differences between NMB use and non-NMB use in the respective mean (95% CI) values for favorable neurological outcomes [53.6 (50.2-57.0) % vs. 58.0 (50.4-65.6) %, p = .304], and survival rates [77.1 (74.7-79.5) % vs. 75.8 (70.5-81.0) %, p = .647].

CONCLUSIONS: The NMB use during TTM was not associated with favorable neurological outcomes and survival rate in patients with OHCA.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Hifumi T, Inoue A, Arimoto H, et al. The association between neuromuscular blockade use during target temperature management and neurological outcomes. Am J Emerg Med. 2020. PMID: 33051089. doi:10.1016/j.ajem.2020.07.078

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。